ICR Documents

Supporting Statement A Document Date Uploaded SUPPORTING STATEMENT FINAL 12-30-13.doc 12/30/2013 Supporting Statement B Document Date Uploaded Supplementary Documents Title Document Document Type Date Uploaded COMMENT BIOTECHNOLOGY IND APPENDIX A 8-26-13 COMMENT BIOTECHNOLOGY IND APPENDIX A 8-26-13.pdf Supplementary Document 12/09/2013 COMMENT EVERYLIFE FOUND Attachment 1 8-26-13 COMMENT EVERYLIFE FOUND Attachment 1 8-26-13.pdf Supplementary Document 12/09/2013 COMMENT HYMAN WITH Attachment 8-27-13 COMMENT HYMAN WITH Attachment 8-27-13.pdf Supplementary Document 12/09/2013 COMMENT HYMAN ATTACHMENT 2 8-27-13 COMMENT HYMAN ATTACHMENT 2 8-27-13.pdf Supplementary Document 12/09/2013 Public Comments Author Name Comment Document Author Affiliation Sponsoring Org. Type Category Date of Comment Date Comment Received Slone, Kelly COMMENT NVCA AND MedIC 8-26-13.pdf Nat'l Venture Capital Associations Medical Innovation and Competitiveness Coalition Letter Simple 08/26/2013 08/29/2013 Koerner, Chin COMMENT NOVARTIS 8-21-13.pdf Novartis Letter Simple 08/21/2013 08/29/2013 Robertson, Andrew COMMENT MERCK CO INC 8-23-13.pdf Merck & Co., Inc. Letter Simple 08/23/2013 08/29/2013 Berg, Nancy S. COMMENT INTERNATIONAL SOCIETY FOR PEs 8-23-13.doc International Society for PE Letter Simple 08/23/2013 08/29/2013 , Anonymous COMMENT ANONYMOUS 8-5-2013.txt Other -- Web Simple 08/05/2013 08/05/2013 Bronstein, Ned COMMENT REGENERON 8-23-13.doc Regeneron Pharmaceuticals Inc. Letter Simple 08/23/2013 08/29/2013 Vereshchagina, Lucy COMMENT PhRMA 8-26-13.pdf PhRMA Letter Simple 08/26/2013 08/26/2013 Hudis, MD., Clifford A. COMMENT AMERICAN SOC OF CLINICAL ONCOLOGY 8-26-13.pdf ASCO Letter Simple 08/25/2013 09/05/2013 Noah, Lara COMMENT AKESIS 8-5-13.txt Akesis Other -- WEB Simple 08/05/2013 08/08/2013 Gonzalez, Sylvia COMMENT GONZELEZ 8-24-13.pdf Letter Simple 08/24/2013 08/24/2013 , Cosigned by 33 Organizations COMMENT EVERYLIFE FOUND LTR 8-26-13.pdf Everylife Foundation Letter Simple 08/26/2013 09/05/2013 , Cancer Leadership Council COMMENT CANCER LEADERSHIP 8-26-13.pdf Letter Simple 08/26/2013 08/29/2013 Morsy, Manal COMMENT ATHERSYS 8-16-13.pdf Athersys, Inc. Letter Simple 08/16/2013 08/16/2013 Haley, Carol COMMENT PFIZER 8-26-13.pdf Pfizer Inc. Letter Simple 08/26/2013 08/29/2013 Clark, Robert B. COMMENT NOVO NORDISK 8-22-13.pdf Novo Nordisk Letter Simple 08/22/2013 09/05/2013 Saltonstall, Peter COMMENT NATIONAL ORG FOR RARE DIS 8-26-13.pdf National Organization for Rare Disorders Letter Simple 08/26/2013 08/29/2013 Velleca, M.D., Mark COMMENT LEUKEMIA and LYMPHOMA SOC 8-26-13.pdf The Leukemia and Lymphoma Society Letter Simple 08/26/2013 08/29/2013 Bronstein, Kathy COMMENT SUDLER AND HENNESSEY 8-8-13.txt Sudler & Hennessey Other -- WEB Simple 07/22/2013 08/08/2013 Furlong, Pat COMMENT PPMD 8-22-13.pdf Parent Project Muscular Dystrophy Letter Simple 08/22/2013 08/29/2013 , Anonymous COMMENT ANONYMOUS 2 8-15-13.txt Other -- WEB Simple 08/15/2013 09/30/2013 Werner, Michael COMMENT ALLIANCE 8-26-13.pdf Alliance Letter Simple 08/26/2013 08/29/2013 Thomasell, James COMMENT ACRP 8-16-13.pdf ACRP Letter Simple 08/16/2013 08/16/2013 Sasinowski, Frank J. COMMENT HYMAN 8-5-13.pdf Hyman, Phelps, McNamara Letter Simple 08/27/2013 08/27/2013 Rohrer, Michelle H. COMMENT GENENTECH 8-26-13.pdf Genentech Letter Simple 08/26/2013 08/29/2013 Beall, Robert COMMENT CYSTIC FIBROSIS 8-26-13.pdf CFF Letter Simple 08/26/2013 08/29/2013 Emmett, Andrew COMMENT BIOTECHNOLOGY IND 8-26-13.pdf Biotechnology Industry Org. Letter Simple 08/26/2013 08/29/2013